These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15232691)

  • 1. [Eradication and chronic acid suppression. Advances and pseudo-advances].
    Turi S; Schilling D; Riemann JF
    Internist (Berl); 2004 Nov; 45(11):1305-14. PubMed ID: 15232691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antireflux therapy--more than acid reduction?].
    Frieling T
    Internist (Berl); 2004 Dec; 45(12):1364-9. PubMed ID: 15480522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
    Rauws EA
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the management of gastro-oesophageal reflux disease.
    Lee JM; O'Morain CA
    Postgrad Med J; 1998 Mar; 74(869):145-50. PubMed ID: 9640439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different treatment choice for first-line treatment of Helicobacter pylori in an area with a high antibiotic resistance.
    Başyiğit S; Kefeli A; Yeniova AÖ; Uzman M; Nazlıgül Y; Aktaş B
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():293-4. PubMed ID: 25910347
    [No Abstract]   [Full Text] [Related]  

  • 6. The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea.
    Chung JW; Lee GH; Han JH; Jeong JY; Choi KS; Kim DH; Jung KW; Choi KD; Song HJ; Jung HY; Kim JH
    Hepatogastroenterology; 2011; 58(105):246-50. PubMed ID: 21510323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease.
    Vakil N
    Gastroenterol Clin North Am; 2015 Sep; 44(3):661-6. PubMed ID: 26314675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Helicobacter pylori Infection in the Proton Pump Inhibitor Era.
    Calvet X
    Gastroenterol Clin North Am; 2015 Sep; 44(3):507-18. PubMed ID: 26314665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use.
    Klok RM; Postma MJ; van Hout BA; Brouwers JR
    Aliment Pharmacol Ther; 2003 May; 17(10):1237-45. PubMed ID: 12755837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Helicobacter pylori eradication on the treatment of gastro-oesophageal reflux disease.
    Richter JE
    Gut; 2004 Feb; 53(2):310-1. PubMed ID: 14724170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors and gastric neoplasia.
    Kuipers EJ
    Gut; 2006 Sep; 55(9):1217-21. PubMed ID: 16905689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastro-oesophageal reflux and Helicobacter pylori.
    Pace F; Bianchi Porro G
    Dig Liver Dis; 2000 Dec; 32 Suppl 3():S202-6. PubMed ID: 11245296
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of Helicobacter pylori infection].
    Lygren I; Andersen LP; Lerang F; Kleveland PM; Farup P; Vatn M; Aursnes I
    Tidsskr Nor Laegeforen; 1998 Nov; 118(29):4511-4. PubMed ID: 9889634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease.
    Malfertheiner P
    Gut; 2004 Feb; 53(2):312-3. PubMed ID: 14724171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
    Wit NJ; Boer WA; Geldof H; Hazelhoff B; Bergmans P; Tytgat GN; Smout AJ
    Aliment Pharmacol Ther; 2004 Aug; 20(4):451-8. PubMed ID: 15298640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice.
    Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Mochizuki S; Matsuo K; Isomura Y; Seto M; Suzuki N; Suzuki H; Yamamoto S; Sugimoto T; Omae T; Okamoto M; Watabe H; Togo G; Takano N; Fukui K; Ito Y; Koike K
    J Dig Dis; 2016 Oct; 17(10):670-675. PubMed ID: 27534444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vonoprazan fumarate for the management of acid-related diseases.
    Martinucci I; Blandizzi C; Bodini G; Marabotto E; Savarino V; Marchi S; de Bortoli N; Savarino E
    Expert Opin Pharmacother; 2017 Aug; 18(11):1145-1152. PubMed ID: 28657473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: bismuth-based therapy for Helicobacter pylori eradication in children.
    Pacifico L; Osborn JF; Anania C; Vaira D; Olivero E; Chiesa C
    Aliment Pharmacol Ther; 2012 May; 35(9):1010-26. PubMed ID: 22404517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes and practice related to Helicobacter pylori infection among primary care physicians.
    Boltin D; Kimchi N; Dickman R; Gingold-Belfer R; Niv Y; Birkenfeld S
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1035-40. PubMed ID: 27167452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.